Related Experiment Video
Updated: Dec 10, 2025

11:44
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.9K
MicroRNA-199a Inhibits Cell Proliferation, Migration, and Invasion and Activates AKT/mTOR Signaling Pathway by
Xiang Yang1, Kai-Xun Feng1, Hu Li1
1Department of Gynecology, 477093Central Hospital of Panyu District, Shiqiao, Guangzhou, People's Republic of China.
Technology in Cancer Research & Treatment
|August 29, 2020
Summary
MicroRNA-199a (miR-199a) is downregulated in cervical cancer, with lower miR-199a levels correlating to increased B7-H3 expression. Overexpressing miR-199a inhibits cervical cancer progression by targeting B7-H3 and activating the AKT/mTOR pathway.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cervical cancer is a significant global health concern.
- MicroRNAs (miRNAs) play crucial roles in tumor invasion and metastasis.
- Decreased microRNA-199a (miR-199a) expression is linked to cervical tumorigenesis.
Purpose of the Study:
- To investigate the role of miR-199a in cervical cancer.
- To identify novel targets of miR-199a in cervical cancer.
- To elucidate the molecular mechanisms underlying miR-199a's function in cervical cancer progression.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) to assess miR-199a and B7-H3 expression.
- Bioinformatics analysis (TargetScan) to predict miR-199a targets.
- Luciferase reporter assay to validate direct targeting.
- Cell proliferation, migration, and invasion assays.
- Western blot analysis.
- In vivo and in vitro studies on the AKT/mTOR signaling pathway.
Main Results:
- miR-199a expression was significantly downregulated in cervical cancer tissues and cell lines compared to normal tissues and immortalized cells.
- B7-H3 expression was significantly upregulated in cervical cancer tissues, inversely correlating with miR-199a levels.
- B7-H3 was identified as a direct target of miR-199a.
- Overexpression of miR-199a inhibited cervical cancer cell proliferation, migration, and invasion by targeting B7-H3.
- miR-199a was found to inhibit tumor progression by targeting B7-H3 and activating the AKT/mTOR signaling pathway.
Conclusions:
- miR-199a directly targets B7-H3 in cervical cancer.
- miR-199a suppresses cervical cancer progression, including proliferation, migration, and invasion, through B7-H3 targeting.
- miR-199a activates the AKT/mTOR signaling pathway by targeting B7-H3, offering insights into cervical cancer pathogenesis.
- These findings support miR-199a as a potential therapeutic target for cervical cancer.
Related Concept Videos
MicroRNAs
3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs
23.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
5.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.0K
Inhibition of Cdk Activity
5.4K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K

